Advances and Novel Treatment Options in Metastatic Melanoma

Advances and Novel Treatment Options in Metastatic Melanoma

The book presents several studies reporting advances on melanoma pathogenesis, diagnosis and therapy. It represents a milestone on the state of the art, updated at 2021, and also presents the current knowledge on the future developments in melanoma field.

Salvato in:
Dettagli Bibliografici
Altri autori: Facchiano, Antonio (Redattore), Del Bufalo, Donatella (Redattore), Carè, Alessandra (Redattore)
Natura: Capitolo di libro
Pubblicazione: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Soggetti:
Medicine
melanoma
invasion
WNT5A
MARCKS
phosphorylation
MANS peptide
nanoparticles
cell therapy
tumor microenvironment
sex/gender
sex-hormones
immunity
microRNAs
immunotherapy
BRAF-mutant melanoma
BRAF inhibitor
mechanism of action
targeted therapy
tumour microenvironment
plasmacytoid dendritic cells
lactate dehydrogenase
TLR
interferon
CXCL10
TPC2
HIPPO
SOCE
metastasis
essential oils
angiogenesis
apoptosis
uveal melanoma (UM)
metastatic uveal melanoma (mUM)
prognostication
adjuvant therapy
metastatic therapy
metastatic dormancy
liver-directed-therapies
targeted-therapy
combined therapy
protein tyrosine phosphatase
PTPs inhibitors
melanoma immune infiltrate
BRAF inhibitors
microenvironment
resistance
therapy
therapeutic resistance
exosomes
extracellular vesicles
diagnosis
prognosis
ctDNA
liquid biopsy
prediction
patient stratification
BRAF
arthralgia
rheumatoid arthritis
carbonic anhydrase
hedgehog
cyclopamine
small molecules
acetazolamide
motility
metalloproteinases
FAK
cancer
mucosal melanoma
nivolumab
pembrolizumab
ipilimumab
radiotherapy
cholinergic system
acetylcholine
muscarinic receptors
nicotinic receptors
melanoma metastasis
ShcD adaptor protein
amoeboid motility
Rac1
DOCK4
melanoma PDX
target therapy
cancer stem cells
slow cycling phenotype
drug resistance
OXPHOS
lipid metabolism
cancer associated fibroblast
melanomagenesis
biomarkers
checkpoint inhibitor
PD-1
melanoma markers
cytokines
machine learning
Support Vector Machine
principal component analysis
BCL2L10
STAT3
cytotoxicity
survival
ABT-737
Bcl-2 family
ML258
HuR
MITF
metastases
siRNA
n/a
Accesso online:Get Fullteks
DOAB: description of the publication
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Accesso online

Get Fullteks
DOAB: description of the publication

3rd Floor Main Library

Dettagli sul posseduto da 3rd Floor Main Library
Collocazione: A1234.567
Copia 1 Disponibile

Documenti analoghi